These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 33147279

  • 1. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
    da Silva CA, Monteiro MLGDR, Araújo LS, Urzedo MG, Rocha LB, Dos Reis MA, Machado JR.
    PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
    Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.
    Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
    [Abstract] [Full Text] [Related]

  • 3. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T, Garola RE, Singh HK.
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [Abstract] [Full Text] [Related]

  • 4. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
    Pereira LHM, da Silva CA, Monteiro MLGDR, Araújo LS, Rocha LP, Reis MBDR, Ramalho FS, Corrêa RRM, Silva MV, Reis MA, Machado JR.
    PLoS One; 2019 Aug; 14(6):e0217569. PubMed ID: 31188898
    [Abstract] [Full Text] [Related]

  • 5. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    Ogawa-Akiyama A, Sugiyama H, Kitagawa M, Tanaka K, Kano Y, Mise K, Otaka N, Tanabe K, Morinaga H, Kinomura M, Uchida HA, Wada J.
    PLoS One; 2020 Aug; 15(1):e0228337. PubMed ID: 31978139
    [Abstract] [Full Text] [Related]

  • 6. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S, Honda K, Ohno M, Uchida K, Nitta K, Oda H.
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [Abstract] [Full Text] [Related]

  • 7. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.
    Am J Physiol Renal Physiol; 2016 Feb 15; 310(4):F322-33. PubMed ID: 26632605
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
    Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y.
    Nephron Clin Pract; 2012 Feb 15; 120(1):c1-7. PubMed ID: 22126861
    [Abstract] [Full Text] [Related]

  • 9. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 Feb 15; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 10. Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies.
    Aparecida Ferreira V, Aparecida da Silva C, Rodrigues do Carmo Neto J, Rocha LP, Monteiro Dos Santos Martins AL, Antônia Dos Reis M, Machado JR.
    Ann Diagn Pathol; 2024 Jun 15; 70():152292. PubMed ID: 38484478
    [Abstract] [Full Text] [Related]

  • 11. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C, Fan Y, Wu J, Shi S, Chen Z, Zhong Y, Zhang C, Zen K, Liu Z.
    J Pathol; 2014 Oct 15; 234(2):203-13. PubMed ID: 24870816
    [Abstract] [Full Text] [Related]

  • 12. Dystroglycan in the diagnosis of FSGS.
    Giannico G, Yang H, Neilson EG, Fogo AB.
    Clin J Am Soc Nephrol; 2009 Nov 15; 4(11):1747-53. PubMed ID: 19808230
    [Abstract] [Full Text] [Related]

  • 13. Approach to Diagnosis and Management of Primary Glomerular Diseases Due to Podocytopathies in Adults: Core Curriculum 2020.
    Ahn W, Bomback AS.
    Am J Kidney Dis; 2020 Jun 15; 75(6):955-964. PubMed ID: 32331832
    [Abstract] [Full Text] [Related]

  • 14. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S, Ginawi I, Bashir AI, Kfoury H, Al Johani TE, Hagar H, Raddaoui L, Al Ghonaim M, Alsuwaida A.
    Ultrastruct Pathol; 2018 Jun 15; 42(5):430-439. PubMed ID: 30285525
    [Abstract] [Full Text] [Related]

  • 15. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

  • 16. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V, Prasad N, Jain M, Pandey R.
    Clin Exp Nephrol; 2013 Dec 01; 17(6):811-8. PubMed ID: 23377573
    [Abstract] [Full Text] [Related]

  • 17. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
    Mizdrak M, Vukojević K, Filipović N, Čapkun V, Benzon B, Durdov MG.
    Diagn Pathol; 2018 Nov 20; 13(1):90. PubMed ID: 30458823
    [Abstract] [Full Text] [Related]

  • 18. Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis.
    Ikezumi Y, Suzuki T, Karasawa T, Yamada T, Hasegawa H, Nishimura H, Uchiyama M.
    Am J Nephrol; 2013 Nov 20; 38(2):149-57. PubMed ID: 23920104
    [Abstract] [Full Text] [Related]

  • 19. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
    Wagrowska-Danilewicz M, Danilewicz M.
    Nefrologia; 2007 Nov 20; 27(6):710-5. PubMed ID: 18336100
    [Abstract] [Full Text] [Related]

  • 20. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.
    Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, Weening JJ, Wetzels JF.
    Kidney Int; 2008 Dec 20; 74(12):1568-76. PubMed ID: 18813290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.